SARS-CoV2 – Page 40 – Communicable Diseases Research

PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis

Review

Published on 2021-12-092022-10-28
Journal: Biomedicines [Category] COVID-19,

Intranasal HD-Ad vaccine protects the upper and lower respiratory tracts of hACE2 mice against SARS-CoV-2

Research

Published on 2021-12-082022-11-01
Journal: Cell & Bioscience [Category] COVID-19,

COVID-19 Impact and Vaccination Willingness among Romanian Patients with Autoimmune/Immune-Mediated Diseases

Article

Published on 2021-12-082022-10-31
Journal: International journal for equity in health [Category] COVID-19,

A Review of SARS-CoV2: Compared With SARS-CoV and MERS-CoV

Medicine

Published on 2021-12-072022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination

Biontech/Pfizer BNT162b2 코로나바이러스 질병 2019 백신 접종에 대한 연령 의존적 면역 반응

Article

Published on 2021-12-062022-09-12
Journal: Clinical Infectious Diseases: An Official Publicat [Category] 진단, 치료기술,

[키워드] acute respiratory syndrome age antibody Antibody Response Antibody titer BNT162b2 cohort study conducted coronavirus coronavirus disease COVID-19 detectable elicited Frequency groups had no humoral Humoral response immune response Immunity immunization Immunoglobulin immunosenescence in both group Infection long-lasting majority Neutralizing Neutralizing antibodies neutralizing antibody Older pandemic participant Participants produced raised remained response revaccination SARS-CoV-2 SARS-CoV-2 spike protein SARS-CoV2 second dose second vaccination significantly lower the antibody response vaccination vaccine dose vaccinee Vaccines
[DOI] 10.1093/cid/ciab381 PMC 바로가기 [Article Type] Article

Biologics for Psoriasis During the COVID-19 Pandemic

Medicine

Published on 2021-12-062022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

Stalling SARS-CoV2 infection with stem cells: can regenerating perinatal tissue mesenchymal stem cells offer a multi-tiered therapeutic approach to COVID-19?

Article

Published on 2021-12-062023-07-02
Journal: Placenta [Category] SARS,

[키워드] Cell therapy COVID-19 Exosomes Mesenchymal stem cells SARS-CoV2
[DOI] 10.1016/j.placenta.2021.12.005 PMC 바로가기 [Article Type] Article

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD

Supplement Articles

Published on 2021-12-052022-10-29
Journal: Journal of the Canadian Association of Gastroenterology [Category] COVID-19,

[키워드] acute respiratory distress age aging Care Chronic illness Comorbidity coronavirus COVID-19 Crohn’s disease database death decrease elderly ENhance expressed extreme General population Health healthcare Hospitalization IBD immune response immune system Impact increase increased risk Inflammatory bowel disease Inflammatory response Influenza information Italy less morbidity and mortality MOST organism Pneumonia reported resources respiratory responses risk robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV2 Satisfaction senescence severe COVID-19 shown syndrome turn ulcerative colitis vaccination Vaccinations while Youth
[DOI] 10.1093/jcag/gwab025 PMC 바로가기 [Article Type] Supplement Articles

Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

Randomized Controlled Trial

Published on 2021-12-042022-10-04
Journal: BMC Research Notes [Category] 임상,

Convalescence plasma treatment of COVID-19: results from a prematurely terminated randomized controlled open-label study in Southern Sweden

Randomized Controlled Trial

Published on 2021-12-042022-10-27
Journal: BMC Research Notes [Category] COVID-19,